John R. Kasich, Governor Orman Hall, Director



Similar documents
Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio

Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings

John R. Kasich, Governor Tracy J. Plouck, Director. Rick Massatti, PhD Brad DeCamp, MPA

How To Treat Anorexic Addiction With Medication Assisted Treatment

Opioid/Opiate Dependent Pregnant Women

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act

Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

Medication Assisted Treatment

Magee-Womens Hospital

Allyse Adams PC, LICDC Oriana House, Inc.

Mental Health and Addiction

2013 OHIO DRUG OVERDOSE DATA: GENERAL FINDINGS 1

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section

Treatment of opioid use disorders

Substance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates

Heroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director

OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines

HOPE Helping Opiate- Addicted Pregnant women Evolve

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction

Title: The Certified Medication Assisted Treatment Advocate (CMA) Training Course

Washington State Interagency Opioid Working Plan

Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay.

Care Management Council submission date: August Contact Information

Joel Millard, DSW, LCSW Dave Felt, LCSW

MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER

Karol Kaltenbach, PhD Maternal Addiction Treatment Education and. Jefferson Medical College Thomas Jefferson University

Medication-Assisted Treatment for Opioid Addiction

Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment

Orange County Heroin Task Force Recommendations

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

Opioid Treatment Services, Office-Based Opioid Treatment

Understanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders

Many public agencies provide services aimed at preventing, reducing, or

Acronyms for the Prevention and Treatment of Substance Use Disorders. Prepared by Mental Health Legal Advisors Committee November 2015

Opioid Use in Pregnancy: A Community s Approach, The Children and Recovering Mothers (CHARM) Collaborative

Federal Response to Opioid Abuse Epidemic

Various therapies are used in the

Addressing Substance Use in Pregnancy

Introduction to Neonatal Abstinence Syndrome

Web-Based Resources. Locating Treatment

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

From the street to the NICU. Richard Christensen, PA, CAS

Opioid overdose can occur when a patient misunderstands the directions

1. THE OPIOID EPIDEMIC IN WISCONSIN ISSUE BRIEF

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery

U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health

Testimony of The New York City Department of Health and Mental Hygiene. before the

Testimony on Addressing Heroin and Opioid Addiction. Theodore Dallas. Secretary, Department of Human Services. Center for Rural Pennsylvania

Beyond SBIRT: Integrating Addiction Medicine into Primary Care

Prescriber Behavior, Pain Treatment and Addiction Treatment

FDA Presentation: Maternal Perspective on Opioid Medication Assisted Therapy

Use of Pharmacotherapies by Substance Abuse Treatment Facilities

REVISED SUBSTANCE ABUSE GRANTMAKING STRATEGY. The New York Community Trust April 2003

Buprenorphine Therapy in Addiction Treatment

MEDICAL POLICY Treatment of Opioid Dependence

Resources for the Prevention and Treatment of Substance Use Disorders

Welcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug

Flagship Priority: Mental Health and Substance Abuse

Neonatal Abstinence Syndrome and Drug Use Among Pregnant Women in Ohio

Neonatal Abstinence Syndrome

Policy Consideration and Collaborative Partnerships: Working with Opioid Dependent Pregnant and Parenting Women

5317 Cherry Lawn Rd, Huntington, WV Phone: (304) Fax: (304) Welcome

EPIDEMIOLOGY OF OPIATE USE

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

Using Drugs to Treat Drug Addiction How it works and why it makes sense

Behavioral Health Provider Implementation of Whole Health Integrative Treatment Services

Treatment Approaches for Drug Addiction

Testimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition

2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California

LOCAL NEEDS LOCAL DECISI NS LOCAL BOARDS

TESTIMONY. March 17, Rutland, VT

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15

Jane Maxwell, UT Addiction Research Institute, Prescription Pain Medications and Heroin: A Changing Picture

Office-based Treatment of Opioid Dependence with Buprenorphine

The ABCs of Medication Assisted Treatment

Methadone and Pregnancy

Identifying and Managing Substance Use During Pregnancy

Transcription:

John R. Kasich, Governor Orman Hall, Director

2

3

Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic than illicit drugs ever have. Prescription Pain Medication (opioids) 600 400 200 Heroin Crack Cocaine 0 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 Source: 1 WONDER (NCHS Compressed Mortality File, 1979-1998 & 1999-2005) 2 2006-2011 ODH Office of Vital 4 Statistics, 3 Change from ICD-9 to ICD-10 coding in 1999 (caution in comparing before and after 1998 and 1999)

5

6

7

8

9

10

11

Percentage Year 12

13

14

Maternal Opiate Medical Support (MOMS) Project In Ohio, the majority of opioid dependent pregnant women are not engaged in prenatal treatment, though evidence-based treatment practices are known. Interventions to increase prenatal treatment will improve outcomes for the mother and child and reduce the cost of Neonatal Abstinence Syndrome (NAS) to Ohio s Medicaid program by shortening length of stay in the Neo-Natal Intensive Care Unit (NICU) for an NAS baby. Primary Project Goals: 1. Develop an integrated maternal care practice model with timely access to appropriate mental health and addiction services that extend postpartum, including intensive home-based or residential treatment. 2. Identify best practices for obstetrical services relating to medication-assisted treatment, before, during and after delivery and develop a toolkit to support clinical practice. 3. Conduct a pilot and evaluation with promising practices at 2-3 sites that will integrate this model into their practice. Total program budget: $4.2 million dollars. Project partners include the Ohio Department of Health, Ohio Medicaid, and the Office of Health Transformation. 15

16

Cases 1200 Diagnosis of drug abuse or dependence at time of delivery, 2007-2011 1000 1061 800 709 815 600 559 640 Cocaine 400 407 490 415 339 368 Opioid 200 0 2007 2008 2009 2010 2011 Year 17

18

NAS inpatient hospitalization rate per 10,000 live births, Ohio, 2004-2011 Source: Ohio Hospital Association 19

Number of inpatient hospitalizations resulting from exposure to noxious substances through breast milk or placenta by substance, Ohio, 2004-2011 Source: Ohio Hospital Association 20

21

Buprenorphine Partial opioid agonist Forms: daily sublingual tablet DEA Schedule III drug; FDA-approved in 2002 Suboxone Partial opioid agonist combination of buprenorphine and naloxone Forms: daily sublingual tablet or film. DEA Schedule III drug; FDA-approved in 2002 Office-based availability: May be prescribed and dispensed by waived physicians in treatment settings other than the traditional Opioid Treatment Program (methadone clinic) setting. Target population: Individuals aged 16 and over with short histories of opioid dependence. 22

Naltrexone Approved for opioid addiction treatment in 1984. Only pure opioid antagonist. Forms: oral and injectable. Vivitrol First approved to treat alcohol dependence in 2006. Approved to treat opiate dependence in 2010. Form: monthly injectable. Most useful for motivated patients who have undergone detoxification and need support to avoid relapse. Helps some patients in beginning stages of opioid use and addiction. Can be prescribed by any healthcare provider who is licensed to prescribe medications- no special training required. 23

NIDA Principles of Effective Drug Addiction Treatment: A Research-Based Guide: Effective treatment attends to multiple needs of the individual. Counseling and other behavioral therapies are critical components of effective treatment. Medications, especially combined with behavioral therapies, are an important element of treatment for many patients. 24

Housing saves the system Essential to reducing the needless cost of homelessness and institutional recidivism Prevents cost shifting to settings such as prisons, jails, shelters, and the ER Reduces costly cycling through crisis-driven systems like foster care, emergency rooms, psychiatric hospitals, emergency domestic violence shelters, detoxification centers, and jails for many persons in poverty Essential to facilitating recovery Provides ability to better participate in the workforce Helps increase financial stability Creates a stronger foundation for the development & education of Ohio's children Contributes to the success of children and youth in school When children have a stable home, they are more likely to succeed socially, emotionally, and academically 25

OhioMHAS has partnered with the Ohio Council of Behavioral Health and Family Services Providers, the Department of Rehabilitation and Correction and the Coalition on Homelessness and Housing in Ohio to provide an open and transparent system of support for recovery housing. OhioMHAS created the Bureau of Housing and Recovery Supports, which is committed to addressing the recovery needs of persons with substance use disorders through planning, development and the implementation of housing initiatives and activities statewide. Work completed: Environmental scan of Ohio s recovery housing Ohio s first Recovery Housing Conference Quarterly Recovery Housing resource meetings Emerging affiliate to the National Alliance of Recovery Residences (NARR) Local Coalition Building Quality Standards Development of a Learning Community that includes in-person and technology-based forums Ohio will develop a recovery housing strategic plan and continue to explore ways to support quality recovery housing. 26

27

-- Ohio Governor John R. Kasich 28

Orman Hall Director Governor s Cabinet Opiate Action Team Ohio Department of Mental Health & Addiction Services 30 E. Broad Street, 36 th Floor Columbus, OH 43215 614.466.2337 Orman.Hall@mha.ohio.gov 29